India's biotech and biomaterials gain EU plaudits:
This article was originally published in Clinica
Executive Summary
India's biotechnology and biomaterials sectors are among those most suited to co-operation between the EU and India, "given the state-of-the-art of science" in the two regions, suggests a European Commission background paper. Though known as the "third world research superpower", India is still underdeveloped, it says. Despite this, the country's biomaterial sciences are featured for their "high-level of expertise", while the National Institute of Immunology and the International Centre for Genetic Engineering and Biotechnology are described as world class institutions. Biotechnology is not currently a priority of its E2.5 billion ($2.2 billion, 0.72% of GDP) R&D budget, 17% of which is provided by industry.